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Abstract
In the first part of this review, the nature of the associations between alcohol use and HIV/AIDS is discussed. Alcohol
use has been found to be strongly associated with incidence and progression of HIV/AIDS, but the extent to which this
association is causal has traditionally remained in question. Experiments where alcohol use has been manipulated as
the independent variable have since helped establish a causal effect of alcohol use on the intention to engage
in condomless sex. As the intention to engage in condomless sex is a surrogate measure of actual condom use
behavior, which itself is linked to HIV incidence and re-infection, the causal chain has been corroborated. Moreover, there
are biological pathways between alcohol use and the course of HIV/AIDS, only in part being mediated by adherence to
antiretroviral medication. In the second part of the contribution, we provide suggestions on the quantification of the link
between alcohol use and HIV incidence, using risk relations derived from experimental data. The biological
links between alcohol use and course of HIV/AIDS are difficult to quantify given the current state of knowledge, except
for an operationalization for the link via adherence to medication based on meta-analyses. The suggested
quantifications are exemplified for South Africa.
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Background
Alcohol use is a major risk factor for burden of disease
and injury [1–4]. It has been shown to affect not only
non-communicable chronic diseases [5, 6] and injuries
[7, 8], but also communicable diseases [9, 10]. To date,
two communicable diseases have been included into the
Global Burden of Disease Comparative Risk Factor Assess-
ment as being causally impacted by alcohol, starting with
the 2010 study ([11]; see also the 2013 [4] and the 2015 [3]
studies): tuberculosis [12, 13] and lower respiratory infec-
tions [14]. The Global Status Report on Alcohol and Health
of the World Health Organization [1] included these
two disease categories as well, but added the effect of
alcohol use on antiretroviral medication adherence
and its impact on AIDS mortality ([15]; based on a
number of reviews [16–20]).
The status of alcohol use as a cause for HIV infec-
tion, and its effects separate from non-adherence, on
the course of HIV/AIDS have been discussed in recent
years [21–23] but were found to be non-conclusive at
a meeting to discuss the causal role of alcohol use on
HIV/AIDS organized by WHO and the South African
Medical Research Council [24]. However, since this
meeting took place, considerable new scientific
evidence seems to support a causal role of alcohol.
Furthermore, systematic reviews and meta-analyses
are now available to allow quantification of the impact
in a way in line with the quantification of other risks
attributable to alcohol or other risk factors in the
global Comparative Risk Assessments (for methodology
see [25]). The present contribution first summarizes the
evidence on the relationship between alcohol use and
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HIV/AIDS, mainly based on systematic reviews and meta-
analyses. In the second part, a methodology to quantify
this impact is introduced.
The establishment of causality is key in these delibera-
tions. Causality is defined here based on Rothman [26–28]
as a multiple components model, where all components
need to be present to produce the effect. In the specific
case for alcohol and HIV incidence, different such sets of
components have been identified, which can be seen as
causal pathways, where alcohol use plays a necessary role
(see below). The case for causality seems convincing,
because in addition to fulfilling the usual epidemio-
logical and thus observational Bradford Hill criteria
[29] such as association, temporality, and plausibility,
we have experimental evidence for key parts of several
pathways, including the pathway of alcohol use on
decision-making.
Review: Alcohol use and HIV/AIDS: association
and causal considerations
Alcohol use was found to be associated with HIV in
recent systematic reviews and meta-analyses [30–36].
Three different explanations have been brought forward
to explain the association: a) the impact of alcohol use
on decision-making, resulting in riskier sexual behaviors
(reviews of [34, 37–43]); b) biological effects of alcohol
use on HIV transmission and disease progression ([44]
as overview; see also [16, 45–47]), including but not
limited to effects of alcohol on treatment course and
medication adherence [16–19, 48]; and c) that most or
all of the effects of alcohol on HIV incidence and disease
progression can be explained by third variables, espe-
cially the effect of risk-taking and other personality vari-
ables [49, 50].
To exclude the third explanation and corroborate the
causality of the alcohol-HIV incidence via impacts on
decision-making on safer sex practices, a number of
experimental trials have been conducted, where alcohol
use was experimentally manipulated as the main factor.
Systematic reviews and meta-analysis of the results of
these trials indicated a causal impact of alcohol use on
decisions about unsafe sex practices, both when alcohol
use was compared to placebo, or to intake of non-
alcoholic beverages [42, 43]. It should be noted that the
underlying experiments have been conducted in different
populations, including people living with HIV (PLWH)
(e.g., [51]).
The reservation must be made that for ethical and
practical reasons, experimental studies, which are neces-
sary to determine causality, can only use surrogate end-
points (i.e., intention for condomless sex) rather than
condomless sex itself or HIV infection. However, the re-
sults of experimental studies corroborate the results of
epidemiological cohort and cross-sectional studies with
condomless sex [34, 37–39, 41, 52–55], sexually transmit-
ted disease [56, 57], or HIV incidence [31] as endpoints.
Moreover, there are meta-analyses that show a clear link
between intentions for unsafe sex and resulting behavior
[58, 59], as well as between condomless sexual practices
and HIV seroconversion [60–62].
The above seems to be in contradiction to some
event-level studies, which have not always found a
negative impact of alcohol on unsafe sex [63, 64].
However, event-level studies have been often done in
select non-probability samples, or via surveys without
adequate control, so that the experimental evidence
mentioned is clearly preferable to control for potential
confounding [65].
With respect to biological impacts, there seems to be
clear evidence that heavy drinking or alcohol use disor-
ders are associated with viral load increases and/or CD4
count declines, general weakening of the immune
system, and more negative outcomes of antiretroviral
therapy (ART), partly mediated by treatment adherence
and partly by the pharmacological interactions of alcohol
with ART and other medications to treat co-morbidities
(for the association regarding adherence see above; for
the other associations see for heavy drinking: [46, 66];
for AUD: [16]; for mechanisms see [20, 46, 48, 67, 68];
for pharmacological interactions see [69, 70]). It should
be noted, however, that delineation of causality in these
biological pathways is difficult, as many factors interact,
and even when causality has potentially been established,
it is hard to quantify the causal contribution of alcohol
to HIV/AIDS disease progression based on biological
mechanisms [20, 66–68, 71].
Quantification of the effect of alcohol use on HIV
The effect of alcohol on decision-making
In a meta-analysis of experimental studies, [42] alcohol
use associated with a blood alcohol concentration (BAC)
level of 0.07 g/dl was shown to impact decision-making
for condomless sex (based on averaging the 28 individual
studies). The latter findings can be used for illustrative
burden of disease quantifications. Participants with a
BAC level of 0.07 g/dl were 1.54 (95% CI 1.31–1.78)
times more likely to consider condomless sex compared
to those who had not used alcohol (see also Additional
file 1). For normal, non-experimental drinking situations,
this BAC would correspond to an average of 49 g pure
alcohol ingested for women and of 61 g for men. The
grams of alcohol corresponding to a BAC of 0.07 g/dl
were derived from standard tables based on sex-specific
average body weight from the National Institute on
Alcohol Abuse and Alcoholism (NIAAA) [72, 73].
In order to quantify the effect of alcohol use on HIV/
AIDS at the population level, we selected people who con-
sume on average at least at this level per day, corresponding
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to a small minority of the drinkers in each country. We
provide the example of South Africa to illustrate these
quantifications in a country with very high prevalence and
burden of HIV/AIDS [74–76] and comparably high levels
of heavy alcohol use among current drinkers [1] (see also
Additional file 1).
There are several assumptions in this choice of opera-
tionalization. First, it assumes that sexually active people
drink at least at the same level as the general population.
Second, it assumes that people with HIV/AIDS continue
to have sex and drink at the same level as the general
population. And third, it is assumed that there are no
interactions with other variables that could change the
causal relation.
The first assumption seems to be without a problem;
at least there is no empirical evidence for the contrary,
and some specific evidence that sexual activity is associ-
ated with drinking in some groups. Regarding the
second set of assumptions, alcohol consumption and
HIV have been shown to be associated among cross-
sectional samples in Africa [35]. This general association
held true, despite the high stigma of alcohol use which
may lead people with HIV or AIDS to withhold report-
ing their drinking status or drinking level, especially if
they are seeking treatment for ART [77, 78]. Some of
the results from Africa for people on ART showed less
involvement with alcohol after treatment initiation,
whereas other findings have demonstrated high alcohol
consumption among ART patients [79, 80]. Regarding
the assumption that people with HIV/AIDS continue to
be sexually active, this has certainly been the case, even
though evidence showed that their level of sexual activity
and condomless sex may be reduced after testing posi-
tive in general, or after ART initiation ([81]; for papers
specifically from South Africa: [82–84]). However, other
evidence from South Africa suggested that alcohol use
was associated with a high likelihood of condomless sex
after a positive HIV test [85]. Overall, the main assump-
tions of the model about continuation of sexual activities
and consumption of alcohol after seroconversion seem
to be justified. The third assumption postulated lack of
interactions. While we cannot control for all these inter-
actions, such as use of vaginal microbicide gels [86] or
socioeconomic status and related malnutrition [87],
many of these seem to increase the impact of alcohol
use on HIV infection.
Illustrative quantification of the effect of alcohol use on
HIV incidence in South Africa
Applying the above-derived drinking level cutoffs results in
29.6% (95% Uncertainty Interval (UI): 24.7%–32.3%) (15.6%
women and 36.8% men; see all UIs in the Additional file 1)
of adult (15 years of age and older) drinkers drinking above
the cutoff; and 12.0% (95% UI: 9.3%–14.1%) (4.1% women
and 20.7% men) of the total adult population. Combining
this exposure, stratified by age, with the risk relations found
in the most recent meta-analysis [42] resulted in the
following estimates with respect to HIV incidence for
South Africa in 2012: 18,200 incident cases (95% UI:
8,400–28,000) (7,000 among women, 11,200 among
men) attributable to alcohol use; population attributable
fraction 3.9% (95% UI: 1.8%–6.0%) (2.2% for women, 7.4%
for men) (incidence data from [88]; for a detailed
description of the methodology and all uncertainty
intervals please see Additional file 1).
Illustrative quantification of the effect of alcohol use on
disease course and mortality including adherence to
medication in South Africa
Combining the above-described sex- and age-specific
exposure estimates with the risk relations reported in
experimental studies yielded population attributable
fractions of 4.5% (95% UI: 2.2%–6.8%) for HIV/AIDS
mortality (2.3% for women and 6.8% for men) and 4.3%
(95% UI: 2.1%–6.5%) (2.2% for women and 6.6% for
men) for HIV/AIDS-related burden of disease, as quanti-
fied in disability-adjusted life years (DALYs) for 2012 in
South Africa (for methodology see Additional file 1).
Combining this burden with the alcohol-attributable
burden of disease caused by non-adherence to highly
active ART (based on [15]), we estimate that in South
Africa in 2012, alcohol use caused 12,200 (95% UI: 6,000–
18,400) HIV- or AIDS-related deaths (2,900 deaths among
women, 9,300 deaths among men); 634,800 (95% UI:
309,300–960,100) HIV/AIDS-related years of life lost due
to premature mortality (YLL; 157,600 YLLs among women,
477,200 YLLs among men); 44,000 (95% UI: 21,300–
66,700) HIV/AIDS-related years lived with disability (YLDs;
11,400 YLDs among women, 32,600 YLDs among men);
and 678,800 (95% UI: 330,600–1,026,800) DALYs (169,100
DALYs among women, 509,700 DALYs among men).
Uncertainty intervals for all estimates can be found in
the Additional file 1.
Discussion
The above estimates are likely to underestimate the
alcohol-attributable HIV incidence and disease burden
for a number of reasons. First, a dose–response relation-
ship has not been quantified, and the estimate reported
above was based on a step function with an increased
risk for a BAC of 0.07 g/dl taken for all BACs above this
threshold. However, a dose–response relationship where
higher levels of BAC correspond with a higher risk to
engage in/consider condomless sex can be expected.
This relationship is hard to quantify, as BAC levels
beyond 0.11 g/dl cannot be tested experimentally for
ethical and practical reasons ([43]; for general dose–re-
sponse relationships between alcohol and other behaviors
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such as drunk driving: [8]). It has also been shown that
even below a BAC of 0.07 g/dl participants were roughly
50% more likely to report the intention of having condom-
less sex compared to those who did not drink alcohol [42].
However, the lower limits for the respective BAC were not
quantified/reported.
Second, the above estimation is based on regular heavy
use and thereby does not include single drinking occa-
sions where a BAC above 0.07 g/dl is reached. This may
have further contributed toward potential underestima-
tion, as irregular heavy drinking occasions are a common
drinking pattern in South Africa [89] and are generally
more prevalent than regular heavy drinking (i.e., an
average daily use above the threshold).
Finally, it should be noticed that the amount of alcohol
needed to reach a specific BAC depends on body weight
(e.g., [90]). The estimation of 49 g and 61 g of pure alcohol
for women and men, respectively, is based on the average
weight in the North American region. As the average
weight in the African region is about 20 kg below the
average weight in the North American Region [91],
the amount of pure alcohol needed to reach a BAC of
0.07 g/dl can be considered as an overestimate for
South Africa.
However, there may also be some attenuation of the
risk relationship, as the link between intention and
actual behavior is not perfect. This may be modeled in
future analyses by including the strength of the associ-
ation between intention and actual behavior from meta-
analyses [58, 59].
Most important, however, is the fact that all the bio-
logical pathways of alcohol use (see above for discussion
and references) are not considered in the current model.
The above-derived population attributable fractions
would also be markedly smaller than any fractions
derived from the classic formulas [92, 93], combining
the prevalence of drinking (around 40% in South Africa
[1]) with relative risk for incident HIV (about 2 overall
for all studies; [31]), which would result in a population-
attributable fraction of 28%.
Overall, the above calculation presents a first approach
to quantifying the impact of alcohol use on incidence of
HIV and disease burden of HIV/AIDS, which goes be-
yond modeling only the effect on medication adherence.
However, while this approach was able to estimate one
additional pathway, there are other pathways such as the
pharmacological effects on the immune system and the
pharmacological interactions with medications, or the
effect of alcohol use on re-infection [94], which remain
to be quantified.
Moreover, different pathways may interact with each
other. Even for the pathway modeled here, in the future
continuous risk functions based on the continuous
exposure distributions need to be created. Thus, while
the current effort is one step to better modeling the
impact of alcohol use on HIV incidence and burden
of HIV/AIDS, more research on the above details is
needed.
While the current paper has been confined to methodo-
logical aspects on the causality of the relationship between
alcohol use and HIV/AIDS and on the quantification of
identified pathways, the results of the review also have
implications for health policy. Given the high impact of
HIV/AIDS on the disease burden in South Africa and
sub- Saharan Africa in general [74, 75, 95], the identifica-
tion of alcohol as a causal factor for incidence opens new
ways to reduce the disease burden of these conditions
[94]. These include classic alcohol policy measures [96] as
well as the integration of alcohol interventions into
the treatment of HIV/AIDS [97].
Conclusion
Alcohol use is strongly associated with the incidence
and course of HIV/AIDS, and based on experimental
data where alcohol use has been manipulated as the
independent variable, a causal effect of alcohol use on
the intention of condomless sex can be asserted. Condom-
less sex intentions can be seen as a surrogate measure of
actual condom use behavior, which itself is linked to HIV
incidence and re-infection. Moreover, there are biological
links between alcohol use and worsening the course of
HIV/AIDS, in part being mediated by adherence to
medication.
To quantify the link between alcohol use and HIV
incidence, we rely on risk relations based on experi-
mental data. Other pathways from alcohol use to HIV/
AIDS burden of disease cannot be quantified given the
current state of knowledge, except for an operationali-
zation for the link via adherence to medication based
on meta-analyses. Overall, this approach to model
alcohol-attributable incidence of HIV and burden of
HIV/AIDS needs to be further developed in the future,
especially with regard to accounting for dose–response
relationships and binge drinking occasions.
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